Cargando…
A population-based assessment of myocarditis after messenger RNA COVID-19 booster vaccination among adult recipients
OBJECTIVES: We aimed to estimate the rate of myocarditis after the messenger RNA (mRNA) COVID-19 booster vaccination by vaccine type, age, and sex. METHODS: We used data from the British Columbia COVID-19 Cohort, a population-based cohort surveillance platform. The exposure was a booster dose of an...
Autores principales: | Naveed, Zaeema, Li, Julia, Naus, Monika, Velásquez García, Héctor Alexander, Wilton, James, Janjua, Naveed Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037911/ https://www.ncbi.nlm.nih.gov/pubmed/36967038 http://dx.doi.org/10.1016/j.ijid.2023.03.027 |
Ejemplares similares
-
Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study
por: Naveed, Zaeema, et al.
Publicado: (2022) -
Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines
por: Naveed, Zaeema, et al.
Publicado: (2022) -
Association of COVID-19 Infection With Incident Diabetes
por: Naveed, Zaeema, et al.
Publicado: (2023) -
Incidence of Myocarditis after Messenger RNA Vaccine for COVID-19 in Young Male Recipients
por: Kato, Shingo, et al.
Publicado: (2022) -
Myocarditis after RNA-based vaccines for coronavirus.
por: Cordero, Alberto, et al.
Publicado: (2022)